{
    "2018-09-28": [
        [
            {
                "time": "2018-09-28",
                "original_text": "Tesla and More Mark End of Quarte; FDA OKs Lilly's Migraine Drug -- ICYMI",
                "features": {
                    "keywords": [
                        "FDA",
                        "Lilly",
                        "Migraine Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Winners and losers for Friday, September 28th",
                "features": {
                    "keywords": [
                        "Winners",
                        "losers"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Health Care Sector Update for 09/28/2018: LLY,SPRO,CCXI,ALDX",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Teva Announces First-to-File Launch of Generic Cialis",
                "features": {
                    "keywords": [
                        "Teva",
                        "Generic Cialis"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Sanofi Stock Up 2.8% in September: What Lies Ahead?",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Stock Up"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "A Look at Eli Lilly’s Revenue Growth Rate",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Revenue Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly's FDA-Approved Migraine Drug is Welcomed by the 38 Million Sufferers",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA-Approved",
                        "Migraine Drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Top Research Reports for Alphabet, Bank of America & PepsiCo",
                "features": {
                    "keywords": [
                        "Research Reports",
                        "Alphabet",
                        "Bank of America",
                        "PepsiCo"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly (LLY) Gets FDA Nod for Migraine Drug Emgality",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA Nod",
                        "Migraine Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Sanofi Stock: How Much Upside Potential Does Wall Street See?",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Stock",
                        "Upside Potential"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "What’s Eli Lilly’s Valuation as of September 27?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Valuation"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Stocks - Tesla Tumbles in Pre-market; Eli Lilly, BlackBerry Gain",
                "features": {
                    "keywords": [
                        "Tesla",
                        "Eli Lilly",
                        "BlackBerry"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "automotive",
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly’s Stock Performance in September",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock Performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Google CEO in DC, Eli Lilly gets green light, Boeing wins big",
                "features": {
                    "keywords": [
                        "Google",
                        "Eli Lilly",
                        "Boeing"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "PFE",
                        "LLY",
                        "Approval",
                        "Novartis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags",
                "features": {
                    "keywords": [
                        "new drugs",
                        "migraine treatment",
                        "price tags"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",
                "features": {
                    "keywords": [
                        "FDA Nods",
                        "Adamis",
                        "Eli Lilly",
                        "Pfizer",
                        "Spero",
                        "Obseva"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "U.S. FDA approves Lilly migraine drug; price same as rivals",
                "features": {
                    "keywords": [
                        "FDA",
                        "Lilly",
                        "migraine drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-09-28",
                "original_text": "Eli Lilly Migraine Drug Approved and Will Be Free to Patients",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Migraine Drug",
                        "Free to Patients"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}